COO
COOPER COMPANIES, INC.
Key Financials
Operating Income
$682.9M
↓ 3.2%
Net Income
$374.9M
↓ 4.4%
Gross Profit
$2.7B
↑ 3.3%
Revenue
$4.1B
↑ 5.1%
Shareholders' Equity
$8.2B
↑ 1.9%
EPS (Diluted)
$1.87
↓ 4.6%
Operating Cash Flow
$796.1M
↑ 12.2%
Total Assets
$12.4B
↑ 0.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/8/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COO |
| Company Name | COOPER COMPANIES, INC. |
| CIK | 711404 |
| Sector | Ophthalmic Goods |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3851 |
| SIC Description | Ophthalmic Goods |
| Entity Type | operating |
| Fiscal Year End | 1031 |
| State of Incorporation | DE |
| Phone | 9254603600 |